EP3008062
Forlyfsafleiður af setnum tríasólópýridínum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
6.6.2014EP published:
5.4.2017EP application number:
14728949.0
EP translation filed:
29.5.2017Grant published:
15.6.2017EPO information:
European Patent Register
Max expiry date:
5.6.2034Expiry date:
5.6.2018
Title:
PRODRUG DERIVATIVES OF SUBSTITUTED TRIAZOLOPYRIDINES
Timeline
Today
6.6.2014EP application
5.4.2017EP Publication
29.5.2017Translation submitted
15.6.2017Registration published
5.6.2018Expires
Owner
Name:
Bayer Pharma AktiengesellschaftAddress:
Müllerstrasse 178, 13353, Berlin, DE
Inventor
Name:
SCHULZE, VolkerAddress:
Hohen NeuendorfOT Bergfelde, DE
Name:
LERCHEN, Hans-GeorgAddress:
Leverkusen, DE
Name:
BIERER, DonaldAddress:
Haan, DE
Name:
WENGNER, Antje MargretAddress:
Berlin, DE
Name:
SIEMEISTER, GerhardAddress:
Berlin, DE
Name:
LIENAU, PhilipAddress:
Berlin, DE
Name:
KRENZ, UrsulaAddress:
Leichlingen, DE
Name:
KOSEMUND, DirkAddress:
Berlin, DE
Name:
STÖCKIGT, DetlefAddress:
Potsdam, DE
Name:
BRÜNING, MichaelAddress:
Schildow, DE
Name:
LÜCKING, UlrichAddress:
Berlin, DE
Name:
TEREBESI, IldikóAddress:
Berlin, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13171508Date:
11.6.2013Country:
EP
Classification
Categories:
C07D 471/04, A61K 31/437, A61P 35/00, A61K 38/00, C07F 9/6561, C07K 5/062, C07K 5/068
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 26.5.2017
Expires: 5.6.2018
Payer: Árnason Faktor